Concepedia

Todd Boland

TB

4

Publications

290

Citations

4

H-Index

2016

Active since

Affiliations

Adimab (United States)(Current)

Todd Boland is an author at Adimab (United States) specializing in natural sciences, protein engineering, and immunotherapy.

Top concepts

MedicineImmunotherapyNatural SciencesProtein EngineeringAntibody EngineeringAllergyImmunologyProteomicsBioanalysisVaccination

Publications per year

2016–2018

4

Publications

4

Deamidation and isomerization liability analysis of 131 clinical-stage antibodies

Xiaojun Lu, R. Paul Nobrega, Heather Lynaugh et al. · mAbs · 2018 · 140 citations · Full text

Peptide Engineering, Relevant Epitope, Immunotherapy +16

Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies

Rong Yang, Tushar Jain, Heather Lynaugh et al. · mAbs · 2017 · 67 citations · Full text

Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learning

Tushar Jain, Todd Boland, Asparouh Lilov et al. · Bioinformatics · 2017 · 57 citations · Full text

Broad epitope coverage of a human in vitro antibody library

Arvind Sivasubramanian, Patricia A. Estep, Heather Lynaugh et al. · mAbs · 2016 · 26 citations · Full text

Immunocytochemical Technique, Epitope Families, Immunology +22

Rows per page

1–4 of 4